Delivery Mode Shapes the Composition of the Lower Airways Microbiota in Newborns.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 05 11 2021
accepted: 10 12 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 29 1 2022
Statut: epublish

Résumé

Radical alterations in the human microbiota composition are well-known to be associated with many pathological conditions. If these aberrations are established at the time of birth, the risk of developing correlated pathologies throughout life is significantly increased. For this reason, all newborns should begin their lives with a proper microbiota in each body district. The present study aimed at demonstrating a correlation between the mode of delivery and the development of a well-balanced microbiota in the lower airways of newborns. 44 pregnant women were enrolled in this study. Microbiological comparative analysis was carried out on tracheobronchial secretions of babies born through vaginal delivery (VD) or caesarean section (CS). All samples showed the presence of bacterial DNA, regardless of the mode of delivery. No viable cultivable bacteria were isolated from the CS samples. On the contrary, VD allowed colonization of the lower airways by alive cultivable bacteria. The identification of bacterial species revealed that

Identifiants

pubmed: 35004360
doi: 10.3389/fcimb.2021.808390
pmc: PMC8733567
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

808390

Informations de copyright

Copyright © 2021 Cardelli, Calvigioni, Vecchione, Macera, Mazzantini, Celandroni, Panattoni, Pistello, Maggi, Ghelardi and Mannella.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hum Reprod. 2001 Sep;16(9):1809-13
pubmed: 11527880
J Mol Med (Berl). 2002 Jan;80(1):44-50
pubmed: 11862324
Nature. 2013 Dec 19;504(7480):451-5
pubmed: 24226773
Int J Cancer. 2005 May 20;115(1):1-5
pubmed: 15688417
Immunity. 2004 Oct;21(4):467-76
pubmed: 15485625
Cell Host Microbe. 2018 Jul 11;24(1):133-145.e5
pubmed: 30001516
J Gen Virol. 2002 Jan;83(Pt 1):141-150
pubmed: 11752710
Pediatrics. 2015 Jan;135(1):e92-8
pubmed: 25452656
Cochrane Database Syst Rev. 2017 Apr 18;4:CD010332
pubmed: 28419406
Arch Virol. 2002 Apr;147(4):803-12
pubmed: 12038689
Cell. 2004 Aug 6;118(3):285-96
pubmed: 15294155
J Clin Microbiol. 1999 Aug;37(8):2538-42
pubmed: 10405397
Sci Rep. 2018 Feb 19;8(1):3255
pubmed: 29459704
J Virol. 2003 Feb;77(4):2418-25
pubmed: 12551979
Microbiome. 2017 Jun 21;5(1):61
pubmed: 28637485
Front Microbiol. 2016 Dec 15;7:1997
pubmed: 28018325
Am J Obstet Gynecol. 2001 Aug;185(2):375-9
pubmed: 11518895
Front Med (Lausanne). 2018 May 04;5:135
pubmed: 29780807
Cell Host Microbe. 2015 May 13;17(5):690-703
pubmed: 25974306
PLoS Pathog. 2005 Dec;1(4):e41
pubmed: 16362076
Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40
pubmed: 12220547
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11971-5
pubmed: 20566857
Int Microbiol. 2001 Mar;4(1):13-9
pubmed: 11770815
EBioMedicine. 2016 Jul;9:336-345
pubmed: 27333043
Front Microbiol. 2018 Apr 10;9:686
pubmed: 29692764
Fertil Steril. 2015 Dec;104(6):1358-63
pubmed: 26493119
Respir Res. 2019 Dec 3;20(1):272
pubmed: 31796027
Sci Transl Med. 2014 May 21;6(237):237ra65
pubmed: 24848255
Virology. 2009 Nov 25;394(2):235-42
pubmed: 19765789
J Matern Fetal Neonatal Med. 2018 Jun;31(11):1448-1453
pubmed: 28420276
Sci Rep. 2020 Dec 9;10(1):21499
pubmed: 33299026
PLoS One. 2012;7(6):e36466
pubmed: 22719832
World J Microbiol Biotechnol. 2019 Oct 13;35(10):161
pubmed: 31608422
DNA Cell Biol. 2014 Dec;33(12):823-9
pubmed: 25188736
J Clin Virol. 2001 May;21(2):135-41
pubmed: 11378494
Nat Med. 2017 Mar;23(3):314-326
pubmed: 28112736
Environ Microbiol. 2021 Mar;23(3):1780-1792
pubmed: 33615652
J Clin Microbiol. 2001 May;39(5):2022-4
pubmed: 11326040
Virchows Arch. 2001 Dec;439(6):752-5
pubmed: 11787846
Appl Environ Microbiol. 2005 Jul;71(7):4117-20
pubmed: 16000830
J Physiol. 2017 Jan 15;595(2):451-463
pubmed: 27373840
J Dermatol Sci. 2017 Aug;87(2):159-167
pubmed: 28433429
Am J Clin Nutr. 2012 Jun;95(6):1323-34
pubmed: 22552027
Sci Rep. 2016 Mar 22;6:23129
pubmed: 27001291
Sci Rep. 2018 Oct 19;8(1):15490
pubmed: 30341363
FEMS Immunol Med Microbiol. 2011 Mar;61(2):153-8
pubmed: 21118312
Front Cell Infect Microbiol. 2020 Jan 10;9:446
pubmed: 31998660

Auteurs

Elisa Cardelli (E)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Marco Calvigioni (M)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Alessandra Vecchione (A)

Microbiology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Lisa Macera (L)

Microbiology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Diletta Mazzantini (D)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Francesco Celandroni (F)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Adelaide Panattoni (A)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Mauro Pistello (M)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Fabrizio Maggi (F)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Emilia Ghelardi (E)

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Paolo Mannella (P)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH